37 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
), the rationale behind the enrollment goals, the subject patient population, potential barriers for enrollment, among others. This Table of Contents 36 … review. Once the submission has been accepted for filing, the FDA begins an in-depth review of the application. Under the goals and policies agreed
ARS
2022 FY
CRBU
Caribou Biosciences Inc
28 Apr 23
Annual report to shareholders
12:00am
, ethnic characteristics, age), the rationale behind the enrollment goals, the subject patient population, potential barriers for enrollment, among … to permit substantive review. Once the submission has been accepted for filing, the FDA begins an in-depth review of the application. Under the goals
DEF 14A
xcehctft c0rtkm
11 Aug 22
Definitive proxy
4:04pm
10-K
EX-10.36
mw1qtx6oa sp14fz
21 Mar 22
Annual report
4:19pm
10-K
EX-10.34
ajsmlstg3r5umv7crfv
21 Mar 22
Annual report
4:19pm
10-K
EX-10.38
knk3ps2sujiq9zvqn
21 Mar 22
Annual report
4:19pm
10-K
EX-10.40
qy6qhx3
21 Mar 22
Annual report
4:19pm
10-K
4vnnr2yianf
21 Mar 22
Annual report
4:19pm
10-K
EX-10.31
ti12794 no
21 Mar 22
Annual report
4:19pm
8-K
EX-10.1
jvcj5swcvqj
19 Jan 22
Entry into a Material Definitive Agreement
4:19pm
S-8
EX-99.6
9m4iva f3rwdg
26 Jul 21
Registration of securities for employees
4:15pm
S-8
EX-99.1
xnxt61jxh6m27o8cs
26 Jul 21
Registration of securities for employees
4:15pm
S-8
EX-99.2
xc1f qx0oec39fq8c
26 Jul 21
Registration of securities for employees
4:15pm
424B4
p50nkyiv
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
EX-10.45
vtts26u
19 Jul 21
IPO registration (amended)
6:09am